Aurora Cannabis Faces Uncertainty Amid Trump's Push for Marijuana Law Reevaluation

President Trump has directed Attorney General Pam Bondi to expedite the reevaluation of marijuana's classification under federal law, potentially reclassifying it to Schedule III. This could impact Aurora Cannabis, a Canadian company operating in the medicinal and recreational cannabis sector. The company faces financial challenges with revenue growth and profitability but maintains a strong balance sheet and liquidity. The reclassification could be a catalyst for future growth, contingent on the company's ability to navigate regulatory changes and market dynamics effectively.